one way or another I believe PYC can achieve the seemingly impossible. Even if they can translate the mouse models to patient derived models/NHP it’ll rock the boat.
If we have the better shot for curing such a horrible disease as ALS, then let us have a shot at brining hope to those suffering.
Hopefully we can get around this block somehow - if we still have the best cargo carrier; is it then a matter of switching out the cargo with a different mechanism of tackling the cellular type, or are we blocked from dabbling in this area completely?
PYC, page-48
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $559.9M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 12.5¢ | 11.0¢ | $333.8K | 2.839M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 252532 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 628395 | 8 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |